142 related articles for article (PubMed ID: 34174340)
1. Long non-coding RNAs correlate with genomic stability in prostate cancer: A clinical outcome and survival analysis.
Jianfeng W; Yutao W; Jianbin B
Genomics; 2021 Sep; 113(5):3141-3151. PubMed ID: 34174340
[TBL] [Abstract][Full Text] [Related]
2. Prediction of bladder cancer outcome by identifying and validating a mutation-derived genomic instability-associated long noncoding RNA (lncRNA) signature.
Wu H; Zhang ZY; Zhang Z; Xiao XY; Gao SL; Lu C; Zuo L; Zhang LF
Bioengineered; 2021 Dec; 12(1):1725-1738. PubMed ID: 33955803
[TBL] [Abstract][Full Text] [Related]
3. Identification and validation of a novel eight mutant-derived long non-coding RNAs signature as a prognostic biomarker for genome instability in low-grade glioma.
Maimaiti A; Wang X; Pei Y; Nuermaimaiti N; Tuersunniyazi A; Abula Y; Feng Z; Jiang L; Shi X; Kasimu M
Aging (Albany NY); 2021 Jun; 13(11):15164-15192. PubMed ID: 34081618
[TBL] [Abstract][Full Text] [Related]
4. Mutator-Derived lncRNA Landscape: A Novel Insight Into the Genomic Instability of Prostate Cancer.
Tang L; Li W; Xu H; Zheng X; Qiu S; He W; Wei Q; Ai J; Yang L; Liu J
Front Oncol; 2022; 12():876531. PubMed ID: 35860569
[TBL] [Abstract][Full Text] [Related]
5. Construction of a genome instability-derived lncRNA-based risk scoring system for the prognosis of hepatocellular carcinoma.
Huang DP; Liao MM; Tong JJ; Yuan WQ; Peng DT; Lai JP; Zeng YH; Qiu YJ; Tong GD
Aging (Albany NY); 2021 Nov; 13(22):24621-24639. PubMed ID: 34799469
[TBL] [Abstract][Full Text] [Related]
6. Computational identification of mutator-derived lncRNA signatures of genome instability for improving the clinical outcome of cancers: a case study in breast cancer.
Bao S; Zhao H; Yuan J; Fan D; Zhang Z; Su J; Zhou M
Brief Bioinform; 2020 Sep; 21(5):1742-1755. PubMed ID: 31665214
[TBL] [Abstract][Full Text] [Related]
7. A computational prognostic model of lncRNA signature for clear cell renal cell carcinoma with genome instability.
Cui T; Guo J; Sun Z
Expert Rev Mol Diagn; 2022 Feb; 22(2):213-222. PubMed ID: 34871123
[TBL] [Abstract][Full Text] [Related]
8. Mutation-Derived Long Noncoding RNA Signature Predicts Survival in Lung Adenocarcinoma.
Yang L; Guo G; Yu X; Wen Y; Lin Y; Zhang R; Zhao D; Huang Z; Wang G; Yan Y; Zhang X; Chen D; Xing W; Wang W; Zeng W; Zhang L
Front Oncol; 2022; 12():780631. PubMed ID: 35372012
[TBL] [Abstract][Full Text] [Related]
9. Genome instability-related LINC02577, LINC01133 and AC107464.2 are lncRNA prognostic markers correlated with immune microenvironment in pancreatic adenocarcinoma.
Zhang Y; Wang Y; He X; Yao R; Fan L; Zhao L; Lu B; Pang Z
BMC Cancer; 2023 May; 23(1):430. PubMed ID: 37173624
[TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA in prostate, bladder, and kidney cancer.
Martens-Uzunova ES; Böttcher R; Croce CM; Jenster G; Visakorpi T; Calin GA
Eur Urol; 2014 Jun; 65(6):1140-51. PubMed ID: 24373479
[TBL] [Abstract][Full Text] [Related]
11. Identification of 10 differently expressed lncRNAs as prognostic biomarkers for prostate adenocarcinoma.
Wu ZY; Wang SG; Li Q; Zhao QS; Shao MM
Math Biosci Eng; 2019 Dec; 17(3):2037-2047. PubMed ID: 32233522
[TBL] [Abstract][Full Text] [Related]
12. Molecular network-based identification of competing endogenous RNAs and mRNA signatures that predict survival in prostate cancer.
Xu N; Wu YP; Yin HB; Xue XY; Gou X
J Transl Med; 2018 Oct; 16(1):274. PubMed ID: 30286759
[TBL] [Abstract][Full Text] [Related]
13. Genomic instability-associated lncRNA signature predicts prognosis and distinct immune landscape in gastric cancer.
Sun J; Jiang Q; Chen H; Zhang Q; Zhao J; Li H; Wang X; Fang Y; Ruan Y; Sun Y
Ann Transl Med; 2021 Aug; 9(16):1326. PubMed ID: 34532463
[TBL] [Abstract][Full Text] [Related]
14. Excavating novel diagnostic and prognostic long non-coding RNAs (lncRNAs) for head and neck squamous cell carcinoma: an integrated bioinformatics analysis of competing endogenous RNAs (ceRNAs) and gene co-expression networks.
Yang L; Lu P; Yang X; Li K; Chen X; Qu S
Bioengineered; 2021 Dec; 12(2):12821-12838. PubMed ID: 34898376
[TBL] [Abstract][Full Text] [Related]
15. Identification of potential autophagy-associated lncRNA in prostate cancer.
Li J; Du H; Chen W; Qiu M; He P; Ma Z
Aging (Albany NY); 2021 May; 13(9):13153-13165. PubMed ID: 33971627
[TBL] [Abstract][Full Text] [Related]
16. Computational detection of a genome instability-derived lncRNA signature for predicting the clinical outcome of lung adenocarcinoma.
Guo CR; Mao Y; Jiang F; Juan CX; Zhou GP; Li N
Cancer Med; 2022 Feb; 11(3):864-879. PubMed ID: 34866362
[TBL] [Abstract][Full Text] [Related]
17. Bioinformatic identification of genomic instability-associated lncRNAs signatures for improving the clinical outcome of cervical cancer by a prognostic model.
Zhang J; Ding N; He Y; Tao C; Liang Z; Xin W; Zhang Q; Wang F
Sci Rep; 2021 Oct; 11(1):20929. PubMed ID: 34686717
[TBL] [Abstract][Full Text] [Related]
18. Computational epigenetic landscape analysis reveals association of CACNA1G-AS1, F11-AS1, NNT-AS1, and MSC-AS1 lncRNAs in prostate cancer progression through aberrant methylation.
Tonmoy MIQ; Fariha A; Hami I; Kar K; Reza HA; Bahadur NM; Hossain MS
Sci Rep; 2022 Jun; 12(1):10260. PubMed ID: 35715447
[TBL] [Abstract][Full Text] [Related]
19. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.
Fan CN; Ma L; Liu N
J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA profile study identifies an immune-related lncRNA prognostic signature for prostate adenocarcinoma.
Liang L; Xia W; Yao L; Wu Q; Hua L; Cheng G; Wang Z; Zhao R
Int Immunopharmacol; 2021 Dec; 101(Pt A):108267. PubMed ID: 34740081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]